Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.
The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果